Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report
Jason D Goldman, Kai Wang, Katharina Röltgen, et al.
Vaccines
|
January 21, 2023
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
Jason D Goldman, Kai Wang, Katharina Röltgen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances
|
July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J Peluso, Saki Takahashi, Jill Hakim, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Cell
|
February 26, 2022
Multiple early factors anticipate post-acute COVID-19 sequelae
Yapeng Su, Dan Yuan, Daniel G Chen, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Reinfection with SARS-CoV-2 and Failure of Humoral Immunity: a case report
Jason D Goldman, Kai Wang, Katharina Röltgen, et al.
Vaccines
|
January 21, 2023
Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report
Jason D Goldman, Kai Wang, Katharina Röltgen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science Advances
|
July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J Peluso, Saki Takahashi, Jill Hakim, et al.
Nature Communications
|
March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Adriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Cell
|
February 26, 2022
Multiple early factors anticipate post-acute COVID-19 sequelae
Yapeng Su, Dan Yuan, Daniel G Chen, et al.
Page
of 11